FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, and concerns application of an antisecretory factor (AF) protein, or a polypeptide, or a derivative of the declared formula I, or a pharmaceutically acceptable salt in preparing a drug for treatment and/or prevention of a state associated with pathologic nerve tissue destruction and/or growth, or for protection. Also, the invention involves a method for treatment and/or prevention of the state associated with pathologic nerve tissue destruction and/or growth, or for protection.
EFFECT: creating the drug allied with a class of proteins naturally formed in an organism.
32 cl, 6 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| LIPID RAFT MODULATION | 2007 |
|
RU2457853C2 |
| METHOD OF SPINAL TISSUE ENGINEERING FOLLOWING ANATOMICAL RUPTURE | 2012 |
|
RU2489176C1 |
| METHOD FOR PRODUCTION OF EGG YOLK WITH HIGH CONTENT OF AF-16 | 2016 |
|
RU2723097C1 |
| METHODS OF NEURAL DISORDER TREATMENT WITH USING HEMATOPOIETIC GROWTH FACTORS | 2003 |
|
RU2353385C2 |
| PRODUCTION OF GABA-ergic NEURONS in vitro OF EMBRYO STEM CELLS AND APPLICATION THEREOF IN TREATING NEURAL DISORDERS | 2004 |
|
RU2380410C2 |
| NEW APPROACH TO TREATMENT OF COMPARTMENT - SYNDROME | 2007 |
|
RU2465914C2 |
| TRANSPLANTATION OF NERVE CELLS FOR TREATMENT OF NEURODEGENERATIVE STATES | 2005 |
|
RU2434636C2 |
| GENE-CELL VESICULAR THERAPEUTIC DRUG AND METHOD FOR MULTIPLE SCLEROSIS THERAPY BY TRANSPLANTATION OF A GENE-CELL VESICULAR THERAPEUTIC DRUG | 2021 |
|
RU2762855C1 |
| INHIBITORS OF SIGNAL TRANSMISSION OF TRANSFORMING GROWTH FACTORS (TGF-R) FOR TREATMENT OF CNS DISORDERS | 2005 |
|
RU2385933C2 |
| METHOD FOR PRODUCING NEURONAL MATRIX | 2010 |
|
RU2431666C1 |
